Entities / Company
Avita Medical.
Australian public company
- Reports this week
- 0
- Active events
- 0
- Connections
- 32
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
PermeaDerm offers a 70% economic advantage over allograft.Some support1 report
-
Avita Medical received multiple international regulatory approvals for its product RECELL on August 1, 2026, including FDA clearance for U.S. use and CE marking in Europe.Some support2 reports
-
Avita Medical received a buy rating reaffirmation from TD Cowen, alongside MarketBeat consensus ratings and SEC insider buying disclosures.Some support1 report
Gone quiet
No new reports in 90+ days-
Avita Medical achieved CE marking for its RECELL GO device in the U.K. on June 18, coinciding with company data presentations and annual meetings in Nottingham.Some support1 report
-
Avita Medical traded on the Nasdaq stock exchange and filed disclosures with the SEC on June 10.Some support2 reports
-
Trump's pledge to unleash oil and gas benefits stocks, with Avita Medical mentioned as an involved entity.Some support2 reports
-
Avita Medical operates as a therapeutic acute wound care company.Speculative1 report
-
Michael Tarnoff was appointed to the Avita Medical Board of Directors on August 7, 2025. Lou Panaccio served as Board Chair for 10 years, while Cary Vance assumed the role of Board Chair.Some support1 report
-
Avita Medical received FDA approval for its RECELL System, granting it exclusive U.S. market rights.Some support4 reports
-
Avita Medical raised capital from Australian investors and issued CDIs quoted on the ASX on August 12, 2025.Some support1 report
-
Research findings by Avita Medical and Victoria Miles were presented at a congress in Berlin.Some support6 reports
No events began in the chosen period. Widen it, or reset.
Around Avita Medical this week
News at the entities that move Avita Medical most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Avita Medical
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Avita Medical
-
Europe StructuralThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Avita Medical
-
TD Cowen Mentioned togetherAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves Avita Medical
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Avita Medical
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves Avita Medical
Connections
The 8 strongest of 32, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates and approves Avita Medical's medical devices, granting them market access.
-
Europe Structural
Avita Medical's market access and operation in Europe are contingent upon receiving formal CE mark regulatory approval.
-
SEC Structural
Avita Medical operates under the formal regulatory oversight of the SEC, requiring company disclosures.
-
Stoke Mandeville Hospital Structural
Stoke Mandeville Hospital utilizes Avita Medical's medical system, establishing a functional supply chain dependency.
-
Zynex Operational
Both companies function as small-cap competitors within the specialized healthcare market.
-
TD Cowen Mentioned together
TD Cowen provided favorable market coverage by reaffirming a buy rating on Avita Medical.
-
Nasdaq Shared context
Avita Medical is listed and trades its shares on the Nasdaq stock exchange.
-
MarketBeat Mentioned together
MarketBeat reports the consensus rating for Avita Medical.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
3 events- PermeaDerm offers a 70% economic advantage over allograft.
- Avita Medical received multiple international regulatory approvals for its product RECELL on August 1, 2026, including FDA clearance for U.S. use and CE marking in Europe.
- Avita Medical received a buy rating reaffirmation from TD Cowen, alongside MarketBeat consensus ratings and SEC insider buying disclosures.
June 2026
8 events- Avita Medical achieved CE marking for its RECELL GO device in the U.K. on June 18, coinciding with company data presentations and annual meetings in Nottingham.
- Avita Medical traded on the Nasdaq stock exchange and filed disclosures with the SEC on June 10.
- Trump's pledge to unleash oil and gas benefits stocks, with Avita Medical mentioned as an involved entity.
- Avita Medical operates as a therapeutic acute wound care company.
- Michael Tarnoff was appointed to the Avita Medical Board of Directors on August 7, 2025. Lou Panaccio served as Board Chair for 10 years, while Cary Vance assumed the role of Board Chair.
- Avita Medical received FDA approval for its RECELL System, granting it exclusive U.S. market rights.
- Avita Medical raised capital from Australian investors and issued CDIs quoted on the ASX on August 12, 2025.
- Research findings by Avita Medical and Victoria Miles were presented at a congress in Berlin.